NAT8
Basic information
Region (hg38): 2:73640723-73642422
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NAT8 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 18 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 18 | 5 | 2 |
Variants in NAT8
This is a list of pathogenic ClinVar variants found in the NAT8 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-73641044-C-G | not specified | Uncertain significance (Feb 16, 2023) | ||
2-73641048-T-G | not specified | Uncertain significance (Oct 27, 2022) | ||
2-73641058-T-A | not specified | Likely benign (Mar 29, 2022) | ||
2-73641097-C-T | not specified | Likely benign (Jan 17, 2024) | ||
2-73641099-G-A | not specified | Uncertain significance (Oct 03, 2022) | ||
2-73641102-T-C | not specified | Uncertain significance (Jan 26, 2022) | ||
2-73641132-C-G | not specified | Uncertain significance (May 23, 2024) | ||
2-73641133-G-A | not specified | Uncertain significance (Dec 19, 2023) | ||
2-73641166-T-C | not specified | Uncertain significance (Aug 05, 2023) | ||
2-73641181-G-C | not specified | Likely benign (Jun 24, 2022) | ||
2-73641184-G-A | not specified | Uncertain significance (Dec 13, 2021) | ||
2-73641222-C-T | not specified | Likely benign (May 09, 2023) | ||
2-73641261-C-A | not specified | Uncertain significance (Apr 15, 2024) | ||
2-73641265-C-T | not specified | Uncertain significance (Oct 12, 2022) | ||
2-73641267-A-G | Benign (Jul 04, 2018) | |||
2-73641268-T-C | not specified | Uncertain significance (Jul 14, 2022) | ||
2-73641294-G-T | not specified | Uncertain significance (Jan 19, 2022) | ||
2-73641316-G-A | not specified | Uncertain significance (Sep 22, 2022) | ||
2-73641318-T-G | not specified | Uncertain significance (Apr 08, 2024) | ||
2-73641325-G-T | not specified | Uncertain significance (Nov 07, 2023) | ||
2-73641347-C-T | not specified | Uncertain significance (Mar 29, 2022) | ||
2-73641381-G-A | not specified | Likely benign (Apr 22, 2024) | ||
2-73641396-G-T | not specified | Uncertain significance (Nov 21, 2022) | ||
2-73641545-A-T | Benign (Mar 30, 2018) | |||
2-73641561-C-T | not specified | Likely benign (Aug 13, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NAT8 | protein_coding | protein_coding | ENST00000272425 | 1 | 1562 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.57 | 186 | 135 | 1.38 | 0.00000799 | 1465 |
Missense in Polyphen | 33 | 24.051 | 1.3721 | 310 | ||
Synonymous | -1.69 | 70 | 54.2 | 1.29 | 0.00000292 | 483 |
Loss of Function |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | ||
East Asian | ||
Finnish | ||
European (Non-Finnish) | ||
Middle Eastern | ||
South Asian | ||
Other |
dbNSFP
Source:
- Function
- FUNCTION: Acetylates the free alpha-amino group of cysteine S- conjugates to form mercapturic acids (PubMed:20392701). This is the final step in a major route for detoxification of a wide variety of reactive electrophiles which starts with their incorporation into glutathione S-conjugates. The glutathione S- conjugates are then further processed into cysteine S-conjugates and finally mercapturic acids which are water soluble and can be readily excreted in urine or bile. Alternatively, may have a lysine N-acetyltransferase activity catalyzing peptidyl-lysine N6- acetylation of various proteins. Thereby, may regulate apoptosis through the acetylation and the regulation of the expression of PROM1 (PubMed:24556617). May also regulate amyloid beta-peptide secretion through acetylation of BACE1 and the regulation of its expression in neurons (PubMed:19011241). {ECO:0000269|PubMed:19011241, ECO:0000269|PubMed:20392701, ECO:0000269|PubMed:24556617}.;
- Pathway
- Glutathione metabolism - Homo sapiens (human);Metapathway biotransformation Phase I and II;Metabolism of proteins;Amyloid fiber formation
(Consensus)
Recessive Scores
- pRec
- 0.742
Intolerance Scores
- loftool
- 0.633
- rvis_EVS
- 0.86
- rvis_percentile_EVS
- 88.74
Haploinsufficiency Scores
- pHI
- 0.279
- hipred
- N
- hipred_score
- 0.123
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.206
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nat8
- Phenotype
Gene ontology
- Biological process
- glutathione metabolic process;positive regulation of gene expression;peptidyl-lysine N6-acetylation;response to drug;negative regulation of apoptotic process;cellular protein metabolic process;amyloid-beta metabolic process
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum membrane;endoplasmic reticulum-Golgi intermediate compartment;integral component of membrane;endoplasmic reticulum-Golgi intermediate compartment membrane
- Molecular function
- lysine N-acetyltransferase activity, acting on acetyl phosphate as donor;protein binding;cysteine-S-conjugate N-acetyltransferase activity